Two early-phase CROs merge
Two US players in the early-phase contract research organisation (CRO) space have announced their intentions to merge.
Archives for December 10, 2007
Eisai continues biologics push with $3.9bn MGI Pharma buy
Japanese drugmaker Eisai has agreed to buy US biopharma firm MGI Pharma for $3.9bn (€2.7bn) in a bid to expand its US presence and strengthen its oncology pipeline.
Galapagos branches out with new GSK deal
GlaxoSmithKline (GSK) is the latest drug firm to involve Galapagos in a new development partnership, in a deal worth up to €218m for the Belgian biotech.